A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation

Clinical trial NCT04656275 · TERMINATED

Trial details

NCT number: NCT04656275
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-cystic Fibrosis Bronchiectasis

Start date: 2021-03-04
Primary completion: 2021-12-20
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.